Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 108.39

+5.5%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Luke who wrote (619)	5/12/1998 9:06:00 PM
From: Platter	of 3202

Vector Securities International upgraded to buy from attractive its rating for INCYTE PHARMACEUTICALS INC based on strong fundamentals and a weak stock price. The share price of Incyte had fallen earlier today on competitive concerns after a report that Perkin-Elmer Corp. was entering a venture to accelerate a project to fully map human DNA, Vector said in a research note. Incyte is a biotech company that designs and markets genomic database products for use in drug development. (Reuters

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next